Head and neck cancers often begin in the mouth, throat, or voice box. They're among the most common cancers in the world, ...

Investigators at the UCLA Health Jonsson Comprehensive Cancer Center have validated a test that can accurately predict which ...

Discover how an emerging technology called tRNA therapy could become the next big thing in genetic disease treatment.

Marks’ resignation leaves the field without a regulator many view as “integral” to its progress over the last decade.

Here is our list of the 11 Best Gene Therapy Stocks to Buy According to Analysts.

Pat Gulhati, MD, PhD, discusses findings from a comprehensive analysis of genetic, immunological, and signaling pathway variations in pancreatic cancer.

Industry updates and investment insights—including investor behavior and fundraising advice—were among the topics experts ...

Yale scientists have discovered a promising way to trigger immune responses against certain tumors, using a lupus-related ...

In a study co-led by the University of Maryland School of Medicine (UMSOM), researchers have identified a “master regulator” ...

Researchers sought to evaluate differences in ctDNA profiles, use of targeted treatments, and overall survival between Black and White patients with metastatic breast cancer.

The GI Cancers Symposium revealed new therapies for specific cancer subsets and progress in chimeric antigen receptor T-cell ...

AUSTIN, Texas, March 26, 2025 /PRNewswire/ -- Genprex, Inc. (GNPX) ("Genprex" or the "Company"), a clinical-stage gene therapy company focused on developing life-changing therapies for patients ...